Genesis CancerCare and Trans-Tasman Radiation Oncology Group Strategic Partnership

trog-smallThe Trans-Tasman Radiation Oncology Group (TROG) is a global leader in radiotherapy research working with over nine hundred researchers and doctors in more than 50 trials involving over 12,000 patient volunteers to help advance cancer treatments. GenesisCare is the leading provider of radiation oncology in Australia undertaking around 320,000 cancer treatments every year and is currently involved in over 40 clinical trials.

GenesisCare and TROG will work together to improve patient access to clinical trials and promote innovation in research to deliver better patient outcomes.


 Bupa Member Benefits

bupaGenesis HeartCare, shares a long partnership with Bupa. As a member, you will be part of a program that aims to improve clinical outcomes for patients with cardiovascular disease. It also guarantees no out-of-pocket expenses for services from Genesis HeartCare cardiologists when you're admitted into hospital. Click here for more information about this partnership. 

Genesis HeartCare - Clinical Outcomes & Quality IndicatorsDownload
















Genesis Logo Small.pngGenesisCare is Australia’s leading provider of radiation oncology, cardiology and sleep treatments. We exist to fill the treatment gap for the biggest disease burdens in Australia - cancer and heart care - in an environment of substantial unmet demand from an ageing population. Click here to learn more